WFA
EDIT icon

Wipfli Financial Advisors’s Editas Medicine EDIT Stock Holding History

Wipfli Financial Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Buy
+97
New +$1.51K ﹤0.01% 2403

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Wipfli Financial Advisors's EDIT Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Editas Medicine (EDIT) in Q3 2022: 97 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2403 among its holdings.

264 funds tracked by Wall St. Rank hold EDIT as of Q3 2022.

  • Wipfli Financial Advisors held 97 shares of Editas Medicine worth $1K as of Q3 2022.
  • Editas Medicine was a new Wipfli Financial Advisors position in Q3 2022.
  • Editas Medicine made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2403 holding.
  • 264 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.